CRP and mucinous neoplasm: Patients treated with scRT were older and had less advanced tumours (cT1-3, cN0, cMRF-, or cEMVI-) according to treatment indication, and had fewer mucinous tumours and shorter tumour lengths, but higher C-reactive protein (CRP) levels.